ImaRx Therapeutics, Inc.

(NASDAQ:IMRX)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 12,861 12,861 12,861 4,256
Cash At End Of Period 2,439 2,146 10,293 12,861
Net Change In Cash And Cash Equivalents -10,422 -10,715 -2,568 8,605
Effect Of Exchange Rate Changes
Net Income Or Loss -10,016 -9,800 -2,530 -8,764
Cash From Operating Activities
Depreciation Expenses 545 448 287 1,174
Amortization Expenses
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses -5,288 198 22 19
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables 349 321 225 227
Increase Or Decrease In Inventories 2,910 1,688 763 2,807
Increase Or Decrease In Prepaid Expenses 400 407 269 -49
Increase Or Decrease In Other Current Assets 400 407 269 -49
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities 96 181 -64 -136
Increase Or Decrease In Other Working Capital -2,777 -1,000 4,417
Other Non Cash Items 1,762
Net Cash From Continuing Operations 4,504 4,541 205 481
Net Cash From Discontinued Operations -6,500 -4,793 -1,823 1,938
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment 2,000
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -11 -11 -11 -577
Acquisitions
Purchase Of Long Term Investments
Purchase Of Short Term Investments
Other Investing Changes Net
Cash From Discontinued Investing Activities
Net Cash From Investing Activities 1,989 -11 -11 -577
Cash From Financing Activities
Issuance Of Debt 12,412
Issuance Of Capital Stock -6,299 -6,299 -1,122 -4,780
Repayment Of Debt
Repurchase Of Capital Stock
Payment Of Cash Dividends 388 388 388 -388
Net Other Financing Charges 388 388 388 -388
Cash From Discontinued Financing Activities
Net Cash From Financing Activities -5,911 -5,911 -734 7,244